« Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptor », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 1, , p. 506–9 (PMID21075630, DOI10.1016/j.bmcl.2010.10.093)
« Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 6, , p. 1748–53 (PMID21316962, DOI10.1016/j.bmcl.2011.01.082)
« Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 8, , p. 2541–6 (PMID21411321, DOI10.1016/j.bmcl.2011.02.023)
« Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain », Bioorganic & Medicinal Chemistry Letters, vol. 22, no 8, , p. 2932–7 (PMID22421020, DOI10.1016/j.bmcl.2012.02.048)
nih.gov
ncbi.nlm.nih.gov
« Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptor », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 1, , p. 506–9 (PMID21075630, DOI10.1016/j.bmcl.2010.10.093)
« Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 6, , p. 1748–53 (PMID21316962, DOI10.1016/j.bmcl.2011.01.082)
« Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 8, , p. 2541–6 (PMID21411321, DOI10.1016/j.bmcl.2011.02.023)
« Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain », Bioorganic & Medicinal Chemistry Letters, vol. 22, no 8, , p. 2932–7 (PMID22421020, DOI10.1016/j.bmcl.2012.02.048)